 |
 | | | | | | |
 | 2014 |
| |
 | 2015 |
| |
  | 01 |
| |
  | 02 |
| |
  | 03 |
| |
  | 04 |
| |
  | 05 |
| |
  | 06 |
| |
  | 07 |
| |
  | 08 |
| |
  | 09 |
| |
  | 10 |
| |
  | 11 |
| |
  | 12 |
| |
| | 12/22/2015 | 02:00 PM | | Merck KGaA, Darmstadt, Germany and Pfizer Advance Clinical Development Program with Two Additional Phase III Trials of Avelumab | |  |
| | 12/21/2015 | 10:00 AM | | Ronastar® Lapis Jewel – For Sparkling Deep Blue Cosmetics | |  |
| | 12/16/2015 | 05:00 PM | | MilliporeSigma Honored by R&D Magazine for Innovation | |  |
| | 12/14/2015 | 10:00 AM | | Merck KGaA, Darmstadt, Germany, Acquires Ormet Circuits | |  |
| | 12/14/2015 | 12:00 PM | | Merck KGaA, Darmstadt, Germany, Helps Refugees in Lebanon | |  |
| | 12/10/2015 | 10:00 AM | | Merck KGaA, Darmstadt, Germany, Confident for 2016 | |  |
| | 12/09/2015 | 05:00 PM | | Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Two Phase III Studies of Investigational Immunotherapy Avelumab in Advanced Gastric and Gastro-esophageal Junction Cancers | |  |
| | 12/07/2015 | 07:15 AM | | Merck KGaA, Darmstadt, Germany, Decides Not to Pursue Evofosfamide Further in Soft Tissue Sarcoma and Pancreatic Cancer | |  |
 | 2016 |
| |
 | 2017 |
| |
 | 2018 |
| |
|